Preoperative therapies for resectable and borderline resectable pancreatic cancer. - Wikidata - awgldk - TriplyDB

Preoperative therapies for resectable and borderline resectable pancreatic cancer.

Preoperative therapies for resectable and borderline resectable pancreatic cancer.

http://www.wikidata.org/entity/Q41836511

about

Borderline resectable pancreatic cancer: definitions and management.Validation of group B borderline resectable pancreatic cancer: retrospective analysis.How to improve the efficacy of endoscopic ultrasound-guided celiac plexus neurolysis in pain management in patients with pancreatic cancer: analysis in a single center.Pancreatic cancer: current standards, research updates and future directions A Comparison of Gastrointestinal Toxicities between Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy for Pancreatic Cancer.The value of liver magnetic resonance imaging in patients with findings of resectable pancreatic cancer on computed tomography.Is a preoperative assessment of the early recurrence of pancreatic cancer possible after complete surgical resection?Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification.The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging.

P2860

Q34067852-522CA7A6-B9DE-4E5A-9A09-F9E00F84678C Q34182126-F3C0DE99-D3F0-4361-B9BF-11CC05D04DCC Q34337587-0434EB8E-EA80-495E-A310-D8B817FC3D81 Q36097184-C2A429FB-F1A2-4DBA-9917-22702D14280E Q36658459-6BCAD5C9-7EA3-49CB-9812-C72ECA8E0DB3 Q37147795-4038085D-7B4B-4EE7-B216-B575F1682E83 Q37563998-BF740472-A67D-4932-A322-3468FF8E0226 Q38838295-9C0DE29B-6AFF-41FF-8C7C-91C5A89477BA Q49200899-7C79DAE9-00F3-4B6D-B16B-08F83D7FA5DB

P2860

Preoperative therapies for resectable and borderline resectable pancreatic cancer.

http://www.wikidata.org/entity/Q41836511

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Preoperative therapies for resectable and borderline resectable pancreatic cancer.

@en

type

label

Preoperative therapies for resectable and borderline resectable pancreatic cancer.

@en

prefLabel

Preoperative therapies for resectable and borderline resectable pancreatic cancer.

@en

P1433

Q41836511-0A280D25-3A48-44EF-9E37-CD76587B0845

P1476

Q41836511-F8BACA26-A42D-4BA7-B678-595C9E3B0CF1

P2093

Q41836511-67FC1AB1-C5A6-41F3-8140-E0551AF068C3

P2860

Q41836511-0115B40F-CBE9-45F6-A0F2-5F4490E9B98A

Q41836511-1C6074CF-40A7-4395-B82B-09F10D5A730C

Q41836511-202CC12B-2E5B-40FD-8B05-3276801C8EC5

Q41836511-4F2FC92B-F478-48FF-A1F9-94EA7E1809C0

Q41836511-51A06888-72E2-476C-8150-7B216D96DDEA

Q41836511-73068767-2695-4D63-BF11-7D5FA8772C2A

Q41836511-752B781D-03F5-462F-AA58-E78AFCD7BE7F

Q41836511-8122A16F-7DBB-44F5-A163-89D133BDCB98

Q41836511-87CC7F2E-54E2-4AA5-8F7C-A2D2416B92F7

Q41836511-87FE86DB-238E-42D4-B574-BDDEAD89E25F

P304

Q41836511-61C7BE9B-E3EA-4252-A0CA-9DDAB9BF8431

P31

Q41836511-EA71444C-5AC8-44E6-86B5-64A87EC801D9

P356

Q41836511-8243D43F-C1B9-48F4-A268-67E304AF9169

P433

Q41836511-9C5DD25C-CA72-4319-8D1A-DBD57E10D4A3

P478

Q41836511-C03D16E4-0A6F-4AAF-9C96-F027D4D324A6

P577

Q41836511-07741D61-14FC-4794-8246-184A67EE0254

P5875

Q41836511-5DF22A7B-5F63-419A-97EF-F066DE5EF705

P698

Q41836511-96F5A97E-F8BE-423B-8EEC-C0A856DCF408

P932

Q41836511-09E24363-92EE-4C96-A293-EB0DF9678DA1

P356

J.ISSN.2078-6891.2011.030

P1433

Journal of gastrointestinal oncology

P1476

Preoperative therapies for resectable and borderline resectable pancreatic cancer.

@en

P2093

Gauri R Varadhachary

http://www.w3.org/2001/XMLSchema#string

P2860

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells

Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity.

Laparoscopy in the staging of pancreatic cancer.

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.

Advanced 3-D imaging for the evaluation of pancreatic cancer with multidetector CT.

P304

136-142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2078-6891.2011.030

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229327062

http://www.w3.org/2001/XMLSchema#string

P698

22811843

http://www.w3.org/2001/XMLSchema#string

P932

3397616

http://www.w3.org/2001/XMLSchema#string